Physician profile
Kevin Murphy
NPI 1346205077
$1,236.54
in general payments reported to CMS, 2019-2025
12 companies · $317 in 2025
The $317 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $120 · 2020: $157 · 2021: $113 · 2022: $167 · 2023: $120 · 2024: $242 · 2025: $317.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $680.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $680.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $300.66 | 2022-2025 | |
| Alcon Vision LLC | $275.39 | 2019-2025 | Tryptyr, Dailies, Dailies Total1 |
| Coopervision INC. | $227.26 | 2019-2024 | Myday Contact Lens, Clariti Contact Lens |
| Dompe US, INC. | $165.43 | 2024-2025 | Oxervate |
| Allergan, INC. | $63.42 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $49.75 | 2020-2022 | |
| Johnson & Johnson Surgical Vision, INC. | $38.36 | 2020 | |
| Amgen INC. | $31.73 | 2024-2025 | Tepezza |
| Sun Pharmaceutical Industries INC. | $28.84 | 2020 | |
| Sight Sciences, INC. | $22.87 | 2023 | Tearcare System |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $19.27 | 2019 | |
| Horizon Therapeutics Plc | $13.56 | 2023 | Tepezza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.